Status:
COMPLETED
Carvedilol Vascular Efficacy Trial
Lead Sponsor:
Elpen Pharmaceutical Co. Inc.
Conditions:
Heart Failure
Acute Myocardial Infarction
Eligibility:
All Genders
18-85 years
Brief Summary
Beta-blockers should be administered to all patients with heart failure stages II to IV NYHA. It should also be administered to patients with stage I after myocardial infarction. The low ejection frac...
Detailed Description
The relationship between stroke volume, which is extruded from the left ventricle gives a measure for the restrictive left ventricular function. Any patient with known cardiovascular disease should un...
Eligibility Criteria
Inclusion
- Patients visiting outpatient clinics.
- Male or female patients over 18 years
- Patients with mild heart failure and history of symptoms according to the instructions of the European Society of Cardiology (ESC)
- Patients who entered the study have LVEF \<40% in echocardiography
- Patients with new diagnosis of heart failure
- Patients who have left ventricular ejection fraction after acute myocardial infarction \<40%
- Patients who have been treated in hospital during the previous month before their inclusion in the study
- Patients who have signed the consent form for recording and processing of personal data.
- Patients who are willing to comply with the requirements of the study
- Patients who are treated with carvedilol for at least a month before their inclusion in this
Exclusion
- Patients under 18 years
- Patients with unstable chronic heart failure
- Patients with unstable hemodynamic profiles
- Patients with heart valve disease
- Patients with hypertrophic cardiomyopathy
- Patients with unstable angina or active myocarditis
- Patients with contraindications to treatment with beta-adrenergic receptors
- Patients who have not consented to recording and processing of personal the data.
- Women pregnant or breastfeeding
- Patients have been treated in hospital during the preceding months before their inclusion in the study
- Patients treated with carvedilol for less than one month
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
415 Patients enrolled
Trial Details
Trial ID
NCT01484327
Start Date
January 1 2009
End Date
November 1 2011
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology University Clinic
Alexandroupoli, Greece